iCAD, Inc. (NASDAQ:ICAD) Short Interest Up 8.7% in October

iCAD, Inc. (NASDAQ:ICAD) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 235,600 shares, an increase of 8.7% from the September 30th total of 216,700 shares. Approximately 0.9% of the company’s stock are sold short. Based on an average trading volume of 157,300 shares, the days-to-cover ratio is currently 1.5 days.

iCAD Stock Down 2.6 %

Shares of NASDAQ ICAD traded down $0.05 during trading hours on Wednesday, hitting $1.85. The company had a trading volume of 65,838 shares, compared to its average volume of 164,277. iCAD has a 1-year low of $1.18 and a 1-year high of $2.65. The firm’s 50 day moving average is $1.62 and its 200-day moving average is $1.50. The stock has a market capitalization of $49.10 million, a P/E ratio of -15.83 and a beta of 1.50.

iCAD (NASDAQ:ICAD) last posted its quarterly earnings results on Tuesday, August 13th. The technology company reported ($0.07) earnings per share for the quarter. The business had revenue of $5.03 million during the quarter. iCAD had a negative net margin of 15.67% and a negative return on equity of 13.59%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ICAD. Essex LLC bought a new stake in iCAD during the third quarter worth $216,000. AMH Equity Ltd bought a new stake in shares of iCAD during the 1st quarter worth $207,000. First Eagle Investment Management LLC boosted its stake in iCAD by 3.2% in the first quarter. First Eagle Investment Management LLC now owns 701,525 shares of the technology company’s stock valued at $1,129,000 after buying an additional 22,000 shares in the last quarter. Perritt Capital Management Inc grew its position in iCAD by 14.2% in the second quarter. Perritt Capital Management Inc now owns 159,900 shares of the technology company’s stock valued at $208,000 after acquiring an additional 19,917 shares during the last quarter. Finally, Perritt Capital Management Inc. grew its position in iCAD by 7.5% in the first quarter. Perritt Capital Management Inc. now owns 139,983 shares of the technology company’s stock valued at $225,000 after acquiring an additional 9,717 shares during the last quarter. Institutional investors and hedge funds own 24.61% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com upgraded iCAD from a “sell” rating to a “hold” rating in a report on Thursday, August 22nd.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.